Table 3 Inhibitory effects of target compounds AS-1: AS-16 on the growth of human cancer cells.

Comp.	Antiproliferative activity IC₅₀ ± SEM (µM)
Comp.	PaCa-2			A-549			MCF-7			PC-3			HT-29
AS-1	8.53	±	1.49	7.9	±	1.18	16.94	±	1.02	17.16	±	1.19	19.74	±	2.14
AS-2	10.88	±	1.9	9.25	±	1.87	17.98	±	1.5	17.97	±	2.13	20.03	±	3.61
AS-3	20.52	±	1.78	15.51	±	0.76	21.06	±	1.53	27.07	±	1.41	25.82	±	1.6
AS-4	22.02	±	1.15	18.8	±	1.34	21.57	±	1.03	33.44	±	1.61	26.28	±	2.93
AS-5	27.81	±	1.5	24.58	±	1.39	34.08	±	1.6	38.6	±	1.29	32.29	±	1.31
AS-6	31.5	±	2.09	25.92	±	0.8	35.38	±	0.77	47.96	±	2.03	37.25	±	0.5
AS-7	11.45	±	2.13	11.13	±	1.17	18.49	±	1.47	19.24	±	2.53	21.76	±	3.33
AS-8	16.67	±	0.82	13.61	±	1.29	20.46	±	1.43	23.59	±	1.28	22.82	±	3.13
AS-9	34.94	±	2.3	27.94	±	1.65	37.61	±	1.63	53.7	±	1.07	42.52	±	1.89
AS-10	35.44	±	0.9	33.55	±	0.87	38.66	±	1.29	54.37	±	1.56	48.33	±	1.34
AS-11	27.38	±	2.23	23.98	±	1.94	32.55	±	1.56	36.22	±	2.39	31.42	±	3.63
AS-12	34.16	±	1.37	26.91	±	0.84	35.44	±	1.42	51.18	±	2.09	39.44	±	1.97
AS-13	28.71	±	0.94	25.66	±	1.99	34.64	±	1.64	47.65	±	1.09	33.74	±	0.87
AS-14	7.7	±	1.52	6.92	±	1.98	10.27	±	0.73	16.02	±	1.41	10.66	±	1.25
AS-15	24.86	±	0.86	22.08	±	1.93	23.71	±	1.52	33.66	±	2.17	27.02	±	0.47
AS-16	26.28	±	1.53	22.27	±	1.34	31.35	±	0.97	36.21	±	0.99	29.54	±	2.91

Quick links

Search